BRAVECTO 112.5 MG CHEWABLE TABLETS VETERINARY इसराइल - अंग्रेज़ी - Ministry of Health

bravecto 112.5 mg chewable tablets veterinary

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 112.5 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

BRAVECTO 112.5 MG SPOT-ON SOLUTION VETERINARY DOGS इसराइल - अंग्रेज़ी - Ministry of Health

bravecto 112.5 mg spot-on solution veterinary dogs

intervet ( israel) ltd - fluralaner - spot-on solution - fluralaner 280 mg / 1 ml - for the treatment of tick and flea infestations in dogs.this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and persistent flea (ctenocephalides felis and ctenocephalides canis) killing activity for 12 weeks, and- immediate and persistent tick (ixodes ricinus, rhipicephalus sanguineus and dermacentor reticulatus) killing activity for 12 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

BRAVECTO 1400 MG CHEWABLE TABLETS VETERINARY इसराइल - अंग्रेज़ी - Ministry of Health

bravecto 1400 mg chewable tablets veterinary

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 1400 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

BRAVECTO 1400 MG SPOT-ON SOLUTION VETERINARY DOGS इसराइल - अंग्रेज़ी - Ministry of Health

bravecto 1400 mg spot-on solution veterinary dogs

intervet ( israel) ltd - fluralaner - spot-on solution - fluralaner 280 mg / 1 ml - for the treatment of tick and flea infestations in dogs.this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and persistent flea (ctenocephalides felis and ctenocephalides canis) killing activity for 12 weeks, and- immediate and persistent tick (ixodes ricinus, rhipicephalus sanguineus and dermacentor reticulatus) killing activity for 12 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

BRAVECTO 250 MG CHEWABLE TABLETS VETERINARY इसराइल - अंग्रेज़ी - Ministry of Health

bravecto 250 mg chewable tablets veterinary

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 250 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

BRAVECTO 250 MG SPOT-ON SOLUTION VETERINARY DOGS इसराइल - अंग्रेज़ी - Ministry of Health

bravecto 250 mg spot-on solution veterinary dogs

intervet ( israel) ltd - fluralaner - spot-on solution - fluralaner 280 mg / 1 ml - for the treatment of tick and flea infestations in dogs.this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and persistent flea (ctenocephalides felis and ctenocephalides canis) killing activity for 12 weeks, and- immediate and persistent tick (ixodes ricinus, rhipicephalus sanguineus and dermacentor reticulatus) killing activity for 12 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

BRAVECTO 500 MG CHEWABLE TABLETS  VETERINARY इसराइल - अंग्रेज़ी - Ministry of Health

bravecto 500 mg chewable tablets veterinary

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 500 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

BRAVECTO 500 MG SPOT-ON SOLUTION VETERINARY DOGS इसराइल - अंग्रेज़ी - Ministry of Health

bravecto 500 mg spot-on solution veterinary dogs

intervet ( israel) ltd - fluralaner - spot-on solution - fluralaner 280 mg / 1 ml - for the treatment of tick and flea infestations in dogs.this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and persistent flea (ctenocephalides felis and ctenocephalides canis) killing activity for 12 weeks, and- immediate and persistent tick (ixodes ricinus, rhipicephalus sanguineus and dermacentor reticulatus) killing activity for 12 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

NEXGARD SPECTRA 150 MG  30 MG VETERINARY इसराइल - अंग्रेज़ी - Ministry of Health

nexgard spectra 150 mg 30 mg veterinary

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - chewable tablets - afoxolaner 150 mg; milbemycin oxime 30 mg - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks.treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis).prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration.prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).

NEXGARD SPECTRA 19 MG  4 MG VETERINARY इसराइल - अंग्रेज़ी - Ministry of Health

nexgard spectra 19 mg 4 mg veterinary

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - chewable tablets - afoxolaner 18.75 mg; milbemycin oxime 3.75 mg - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks.treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis).prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration.prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).